The landscape of dementia prognosis has developed substantially with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades in advance of signs or symptoms emerge. Whilst these technological advances characterize impressive progress in understanding neurodegenerative health conditi... https://kurtz086bku6.dm-blog.com/profile